A study drawing on hundreds of thousands of UK Biobank participants and published in Nature Aging has mapped a clear U-shaped curve between sleep duration and the biological age of the brain, liver, and other organs. Those who habitually sleep between roughly six-and-a-half and eight hours show the least organ-level ageing. Below six hours, all-cause mortality risk climbs by about 50 per cent compared with the ideal band; above eight hours, it rises by roughly 40 per cent. The finding reframes sleep not as a matter of personal stamina but as a quantifiable physiological regulator, with both insufficiency and excess acting as independent stress signals on the body.

Mechanistically, the damage from insufficient sleep operates through several channels. A US National Institutes of Health-backed analysis of more than 4,500 middle-aged and older adults identified hypoxic burden—the accumulated drop in blood oxygen during sleep—as the primary driver of cardiovascular harm. Each incremental reduction in oxygen raised the risk of a primary cardiovascular event by 45 per cent, and airway obstruction alone accounted for 38 per cent of that risk, independent of obesity or lung function. Separately, even a single night of four hours’ sleep or total deprivation reduces muscle force production by 10 to 15 per cent in men and endurance by 7 to 12 per cent in women, while shifting the body’s fuel use toward fat in a compensatory, not beneficial, metabolic response marked by reduced insulin sensitivity and elevated cortisol. Excessive sleep, by contrast, often signals underlying pathology: a meta-analysis found a 28 per cent higher dementia risk among those reporting more than eight hours, and researchers in Brazil note that prolonged time in bed frequently masks fragmented, non-restorative sleep.

In clinical practice, the consequences are stark. Data from nearly 890,000 older US veterans diagnosed with obstructive sleep apnoea show that only 32.6 per cent initiated treatment, yet those who used positive airway pressure therapy saw a 47 per cent reduction in all-cause mortality and a 10 per cent lower risk of major cardiovascular events. In Mexico, where 27.3 per cent of men and 22.5 per cent of women have a high probability of sleep apnoea, the condition is frequently underdiagnosed because its symptoms—fatigue, daytime sleepiness—are mistaken for normal ageing. Parallel to sleep, cholesterol management remains a cornerstone of cardiovascular prevention. Cardiologists in Buenos Aires report that 40 per cent of Argentine adults have elevated total cholesterol, and they stress that while statins are effective, dietary patterns are equally critical: plant-based foods rich in soluble fibre directly lower LDL, and post-dinner habits such as a short walk, avoiding late-night ultra-processed snacks, and preparing meals in advance can reinforce both lipid control and sleep quality.

Viewed together, the evidence pushes toward an integrated model of cardiovascular and brain health in which sleep duration, sleep quality, and nutritional routines are not separate domains but mutually reinforcing levers. The next milestone to watch is the incorporation of sleep metrics into standard cardiovascular risk calculators, a step under active discussion by several international guideline bodies, alongside expanded screening for sleep apnoea in primary care across Latin America.